BATTAGLIA, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 6.418
EU - Europa 693
AS - Asia 333
OC - Oceania 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 7.457
Nazione #
US - Stati Uniti d'America 6.414
CN - Cina 266
SE - Svezia 150
FI - Finlandia 144
UA - Ucraina 122
DE - Germania 93
IT - Italia 75
GB - Regno Unito 70
VN - Vietnam 45
IN - India 16
IE - Irlanda 14
FR - Francia 6
GR - Grecia 6
NL - Olanda 6
AU - Australia 4
CA - Canada 3
EG - Egitto 3
ES - Italia 2
EU - Europa 2
IR - Iran 2
LU - Lussemburgo 2
RS - Serbia 2
AR - Argentina 1
BT - Bhutan 1
CH - Svizzera 1
JP - Giappone 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
UG - Uganda 1
Totale 7.457
Città #
Fairfield 956
Houston 776
Woodbridge 701
Ann Arbor 511
Jacksonville 496
Chandler 479
Ashburn 409
Wilmington 378
Seattle 337
Cambridge 316
Princeton 187
San Diego 95
Roxbury 83
Beijing 64
Boardman 60
Des Moines 60
Nanjing 56
Helsinki 51
Medford 49
Dong Ket 44
Guangzhou 26
Norwalk 21
Falls Church 20
Nanchang 19
Padova 18
New York 17
Shenyang 16
Hebei 14
Dublin 13
London 11
Redwood City 11
Pune 10
Tianjin 9
Jiaxing 8
Jinan 8
Kharkiv 7
Kilburn 7
Milan 7
Changsha 6
Shanghai 6
Indiana 5
Ogden 5
Columbus 4
Dearborn 4
New Bedfont 4
Taizhou 4
Zhengzhou 4
Alexandria 3
Auburn Hills 3
Borås 3
Kunming 3
Ningbo 3
Vicenza 3
Ardabil 2
Belgrade 2
Buffalo 2
Chicago 2
Costa Mesa 2
Dallas 2
Edinburgh 2
Hangzhou 2
Hefei 2
Hounslow 2
Luxembourg 2
Mestre 2
Morengo 2
Orange 2
San Francisco 2
Stuttgart 2
Washington 2
Zaragoza 2
Albany 1
Almere Stad 1
Asunción 1
Breganze 1
Brisbane 1
Chiswick 1
Colombo 1
Dortmund 1
Droichead Nua 1
Easton 1
Haikou 1
Hanover 1
Huzhou 1
La Canada Flintridge 1
Los Angeles 1
Manila 1
Marcon 1
Melbourne 1
Munich 1
Nishinotoindori 1
North York 1
Ontario 1
Palermo 1
Panama City 1
Paris 1
Perth 1
Prescot 1
Redmond 1
Rockville 1
Totale 6.475
Nome #
Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus 160
Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis 149
The Veneto Region's Barrett's Oesophagus Registry: Aims, methods, preliminary results. 141
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. 135
A germline predictive signature of response to platinum chemotherapy in esophageal cancer 133
Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett’s esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population 123
Barrett's epithelium after antireflux surgery 119
In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma 114
Comparison of preoperative and surgical measurements of Zenker's diverticulum. 113
Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. 112
Aurora kinase A in Barrett's carcinogenesis. 111
Programmed cell death 4 protein in esophageal cancer 110
A new endoscopic technique for suspension of esophageal prosthesis for refractory caustic esophageal strictures 110
CYTOPROTECTIVE EFFECTS OF COLLOIDAL BISMUTH SUBCITRATE IN PATIENTS WITH ULCER DISEASE 108
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study. 105
Erosion of an esophageal endoprosthesis into the trachea 105
The Role of Helicobacter pylori in the Spectrum of Barrett's Carcinogenesis 104
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. 104
Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagus 104
A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia 103
Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. 102
Caustic ingestion and oesophageal cancer: intra- and peri-tumoral fibrosis is associated with a better prognosis 100
PALLIATIVE TREATMENT OF HEPATOCELLULAR CARCINOMA WITH TRANSCATHETER ARTERIAL EMBOLIZATION. 98
MicroRNA expression profiling in human Barrett's carcinogenesis. 98
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study. 96
Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia 95
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 94
Endoscopic treatment of pseudosarcomatous squamous carcinoma of the esophagus: case report and personal experience 94
Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia 93
Etiology, diagnosis and treatment of failures after laparoscopic Heller Myotomy for achalasia 89
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis (vol 63, pg 692, 2010) 88
Helicobacter pylori in promotion of gastric carcinogenesis 87
The Experience on PDT by the Multidisciplinary Group in Padova 86
Programmed cell desth 4 (PDCD4) expression during multistep Barett's carcinogenesis. 85
Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia 85
Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy. 84
Prediction of lymph node status in superficial esophageal carcinoma. 83
Management of esophageal cancer in patients aged over 80 years. 83
Role of Confocal Laser Endomicroscopy in Detection of Residual Barrett's Esophagus after Radiofrequency Ablation 80
H-pylori eradication in gastric ulcer disease: One year prospective multicenter study 79
High-frequency miniprobes and 3-dimensional EUS for preoperative evaluation of the etiology of congenital esophageal stenosis in children (with video). 77
Mediastinal carcinosis involving the esophagus in breast cancer: the"breast-esophagus" syndrome: report on 25 cases and guidelines for diagnosis andtreatment. 77
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. 76
Endoscopic ultrasound: accuracy in staging superficial carcinomas of the esophagus 76
The role of flexible endotherapy for the treatment of recurrent Zenker’s diverticula after surgery and endoscopic stapling 76
Barrett’s Esophagus and Adenocarcinoma Risk The Experience of the North-Eastern Italian Registry (EBRA) 75
CEFIXIME FOR THE ERADICATION OF HELICOBACTER-PYLORI 73
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study. 73
Gastrointestinal stromal tumors: report of an audit and review of the literature 72
Single-band mucosectomy for granular cell tumor of the esophagus: safe and easy technique 72
SERUM PEPSINOGEN-A AND PEPSINOGEN-C LEVELS - A FOLLOW-UP-STUDY ON 476 PATIENTS AFTER HELICOBACTER-PYLORI ERADICATION 71
EARLY DROP IN ANTIHELICOBACTER-PYLORI IGG TITER AFTER ERADICATION THERAPY WITH CLARITHROMYCIN 70
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 70
Azithromycin for the cure of Helicobacter pylori infection 69
Hybrid patch-based and image-wide classification of confocal laser endomicroscopy images in Barrett’s esophagus surveillance 69
Retreatment after failure of Helicobacter pylori eradication: Quadruple vs ranitidine bismuth citrate 2 weeks therapy. 68
Anastomotic stenoses occurring after circular stapling in esophageal cancer surgery 68
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 years study 67
TREATMENT OF LIVER ABSCESS:PERCUTANEOUS CATHETER DRAINAGE VERSUS SURGICAL DRAINAGE. 67
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey 67
Barrett's epithelium after antireflux surgery 65
COMPARISON OF 3 DIFFERENT THERAPEUTIC REGIMENS FOR ERADICATING HELICOBACTER-PYLORI 62
Long‐Term pH and Manometric Evaluation of the Distal Esophagus After Endoscopic Sclerotherapy of Esophageal Varices 61
One year prospective multicenter study after eradication in Helicobacter pylori positive gastric ulcer disease. 60
Barrett's esophagus: management of high-grade dysplasia and cancer 60
Visceral fistula as a complication of endoscopic treatment of esophageal and gastric varices using isobutyl-2-cyanoacrylate: report of two cases 60
Detection of fluorescent organic nanoparticles by confocal laser endomicroscopy in a rat model of Barrett's esophageal adenocarcinoma 60
LA DIAGNOSI E LA TERAPIA ENDOSCOPICA DELLE EMORRAGIE DIGESTIVE ALTE 58
PPIS plus H-2-antagonists for non-responders GERD patients: A rescue therapy? (A three months pilot study). 58
AZITHROMYCIN - A NEW USEFUL THERAPEUTIC STRATEGY FOR THE ERADICATION OF HELICOBACTER-PYLORI INFECTION - MODIFICATION OF SERUM GASTRIN, PEPSINOGENS AND ANTI-HP ANTIBODIES (IGG) 57
The prevalence of esophagitis in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: One year follow-up. 56
Four Hundred Laparoscopic Myotomies for Esophageal Achalasia A Single Centre Experience 56
LA LEGATURA DELLE VARICI ESOFAGEE: UNA NUOVA TECNICA ENDOSCOPICA 54
Computer Aided Diagnosis of Barrett's Esophagus Using Confocal Laser Endomicroscopy: Preliminary Data 54
Role of acid and bile reflux in development of specialised intestinal metaplasia in distal oesophagus 54
An unusual complication of eosinophilic esophagitis in an adolescent: intramural esophageal dissection. 53
Diagnosis and Endoscopic Management of Barrett's Esophagus: an Italian Experts’ Opinion based document 53
Quadruple therapy versus ranitidine bismuth citrate after failure of standard triple therapy 52
IMPLICAZIONI RADIOLOGICHE DELLA SCLEROSI ENDOSCOPICA CON CIANOACRILATO DELLE VARICI GASTRICHE. 52
Enteryx(tm) implantation in the treatment of GERD: Results of a national, multicentre study in Italy confirm prior efficacy results 52
Hemodynamic changes on systemic, hepatic and splenic circulations following triglycyl-lysin-va¬sopressin administration in alcoholic cirrhosis. 52
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). 48
Helicobacter pylori eradication in gastric ulcer disease: One year prospective multicenter study 47
Effects of nadolol treatment on renal and hepatic haemodynamics and function in cirrhotic patients with portal hypertension. 47
The "very bed" H pylori: Experience on 69 consecutive patients after the failure of the second eradication treatment. 45
EFFETTI EMODINAMICI DELLA TRYGLYCYL-LYSINE-VASOPRESSIN: STUDIO ANGIOGRAFICO. 44
MicroRNA Expression Profiling of Human Esophageal Metaplastic Changes 44
TERAPIA ENDOSCOPICA DELLE VARICI GASTRICHE CON CIANOACRILATO 43
Is non ulcer dyspepsia an indication for Helicobacter pylori eradication? A one year prospective study. 42
Polyflex stents for malignant oesophageal and oesophagogastric stricture: aprospective, multicentric study. 42
Computer Aided Diagnosis Of Barrett’s Esophagus And Associated Neoplasia Using Confocal Laser Endomicroscopy 41
Derivazione spleno-renale distale selettiva vs devascolarizzazione esofago-gastrica con transezione esofagea. Studio prospettico controllato. 41
Which stent stenosis of the esophagus which [Quale stent in quale stenosi dell'esofago]. 40
The role of acid and bile reflux in the development of specialized metaplasia in the distal esophagus 31
TRATTAMENTO PALLIATIVO DELL'EPATOCARCINOMA NON RESECABILE CON CHEMIOEMBOLIZZAZIONE. 31
Computer Aided Diagnosis Of Barrett’s Esophagus And Associated Neoplasia Using Confocal Laser Endomicroscopy: Preliminary Data 27
Helicobacter pylori eradication in functional dyspepsia: A prospective randomized six months study. 27
Ulcera duodenale e iperpepsinogenemi: decorso clinico e risposta gastrinemica al pasto 25
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-easth Italy: A prospective descriptive survey. The Italian Ulcer Study Group (GISU) 23
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). 16
Totale 7.488
Categoria #
all - tutte 22.177
article - articoli 21.576
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.753


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019518 0 0 0 0 0 0 0 0 0 110 214 194
2019/20201.681 202 97 34 199 164 137 140 192 162 167 101 86
2020/20211.063 65 100 68 111 38 75 22 118 168 81 117 100
2021/20221.271 39 152 162 90 63 71 47 153 53 24 142 275
2022/2023997 229 89 28 127 178 139 0 52 115 5 28 7
2023/2024334 20 81 37 35 35 61 20 24 16 5 0 0
Totale 7.488